Table 1 Clinical response to anti-tumour necrosis factor alpha treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies
Mean Disease Activity Score 44 | P | |
|---|---|---|
At onset | 5.56 | |
6th month | 3.38 | 0.006 |
12th month | 3.41 | 0.03 |
18th month | 3.33 | 0.01 |
24th month | 2.88 | 0.006 |